This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Enantis S.r.o., Masarykova Univerzita. Active years: 2023.
Company Filing History:
1 out of 1 
1 out of 15 Years Active: 2023
Title: Michaela Bosakova: Innovator in Thermostable Polypeptides
Introduction
Michaela Bosakova is a prominent inventor based in Brno, Czech Republic. She has made significant contributions to the field of cell biology and regenerative medicine through her innovative research and patents. Her work focuses on the development of thermostable polypeptides, which have important applications in various medical and cosmetic fields.
Latest Patents
Michaela holds a patent for a thermostable FGF2 polypeptide, which is characterized by its isolated nature and FGF2 activity. This polypeptide exhibits at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) and includes at least one amino acid substitution, specifically R31L. The invention outlines its use in cell biology research, regenerative medicine, and related medical applications, as well as in cosmetics. Additionally, it describes a culture medium that incorporates the subjected FGF2, which is suitable for culturing human pluripotent stem cells, including both human embryonic stem cells and induced pluripotent stem cells.
Career Highlights
Throughout her career, Michaela has worked with notable institutions, including Masaryk University and Enantis s.r.o. Her research has been pivotal in advancing the understanding and application of polypeptides in scientific and medical contexts.
Collaborations
Michaela has collaborated with esteemed colleagues such as Petr Dvorak and Eva Sebestova, contributing to a rich exchange of ideas and expertise in her field.
Conclusion
Michaela Bosakova's innovative work in the development of thermostable polypeptides showcases her dedication to advancing medical science and technology. Her contributions are expected to have a lasting impact on regenerative medicine and related applications.